share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.9%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.9%)

SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.9%)
美股SEC公告 ·  2024/05/08 14:24

Moomoo AI 已提取核心信息

On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.
On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.
2024年4月30日,总部位于特拉华州的投资管理公司贝莱德公司向美国证券交易委员会(SEC)提交了经修订的附表13G,表明其持有的Cardio Diagnostics Holdings Inc.普通股发生了变化。该文件是1934年《证券交易法》对某些所有权门槛的要求,显示贝莱德现在实益拥有1,067,062股股票,占公司普通股类别的4.9%。这标志着所有权的减少,因为贝莱德已经勾选了表明其持有该类别证券的比例不再超过5%的复选框。该文件由贝莱德公司事实律师斯宾塞·弗莱明签署,据签署人所知,所提供的信息经认证为真实和完整。
2024年4月30日,总部位于特拉华州的投资管理公司贝莱德公司向美国证券交易委员会(SEC)提交了经修订的附表13G,表明其持有的Cardio Diagnostics Holdings Inc.普通股发生了变化。该文件是1934年《证券交易法》对某些所有权门槛的要求,显示贝莱德现在实益拥有1,067,062股股票,占公司普通股类别的4.9%。这标志着所有权的减少,因为贝莱德已经勾选了表明其持有该类别证券的比例不再超过5%的复选框。该文件由贝莱德公司事实律师斯宾塞·弗莱明签署,据签署人所知,所提供的信息经认证为真实和完整。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息